- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06765044
Textbook Outcomes in Urgent Appendectomy (APPX_TEXTBOOK)
Textbook Outcomes of Surgical Treatment of Acute Appendicitis
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Ana Maria Gonzalez Castillo PhD, PhD
- Phone Number: +34665126866
- Email: amgonzalezcastillo@gmail.com
Study Contact Backup
- Name: Ana Maria González Castillo PhD, PhD
- Email: amgonzalezcastillo@gmail.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Acute Appendicits in older than 18 years old
- Acute Appendicitis that needs appendectomy
Exclusion Criteria:
- Age under 18 years old
- Other diagnostic than an Acute Appendicitis
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Textbook Outcomes
Time Frame: 2022-2024
|
Classical assessments, focused solely on mortality and morbidity, are increasingly considered insufficient.
A more comprehensive approach, using composite measures, offers a more accurate evaluation, providing a multidimensional view and patient-centred healthcare appraisal.
The textbook outcome (TO) is the most used objective composite measure to compare surgical quality across centres
|
2022-2024
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Appendectomy in less than 24h
Time Frame: 2022-2024
|
From diagnostic of Acute Appendicitus to Surgical Treatment should be less than 24h
|
2022-2024
|
|
Hospital Stay less than 5 days
Time Frame: 2022-2024
|
Optimal hospital stay should be less than 5 days
|
2022-2024
|
|
Intraoperative incidences
Time Frame: 2022-2024
|
Intraoperative bleeding, perforation of the appendix, iatrogenic injury to other structures
|
2022-2024
|
|
Short antibiotics treatment
Time Frame: 2022-2024
|
Less than 72h of antibiotic treatment
|
2022-2024
|
|
Patient comorbidities
Time Frame: 2022-2024
|
Charlson Comorbidity Index
|
2022-2024
|
|
Surgical Risk
Time Frame: 2022-2024
|
ASA Scoring System
|
2022-2024
|
|
Intraoperative appendicitis gradding
Time Frame: 2022-2024
|
AAST classification AAST I: Acutely inflamed appendix, intact. AAST II:Gangrenous appendix, intact AAST III:Above, with evidence of local contamination AAST IV:Above, with abscess or phlegmon in region of appendix AAST V:Above, with addition of generalized purulent contamination away from appendix WSES Classification: Grade- 0 (normal looking) Grade-1 (inflamed) Grade- 2A and 2B (necrosis) Grade- 3A - 3B - 3C (perforated - inflammatory tumor) Grade- 4 (perforate - diffuse peritonitis) |
2022-2024
|
|
Postperative complications
Time Frame: 2022-2024
|
Clavien Dindo and CCI (https://www.cci-calculator.com/) Grade I: Any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic, and radiological interventions. Grade II:Requiring pharmacological treatment with drugs other than such allowed for Grade I Grade III:Requiring surgical, endoscopic or radiological intervention. Grade IV:Life-threatening complication (including CNS complications)* requiring IC/ICU-management with single or multiorgan disfunction. Grade V: Death of a patient |
2022-2024
|
|
Readmision index
Time Frame: 2022-2024
|
Percentage of readmission
|
2022-2024
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Appendicitis Textbook Outomes
- CEIm number (Other Identifier: Hospital del Mar)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Valid MeSH Conditions
-
Max Healthcare Insititute LimitedCompleted
-
DejthidaNathaphongActive, not recruitingHypertension (HTN) | Valid MeSH ConditionsThailand
-
Taipei Medical UniversityActive, not recruitingValid Malnutrition Condition | Valid Sarcopenia | Valid FrailtyTaiwan
-
Kıvanç AkçaHacettepe UniversityCompletedCementation (MeSH Unique ID: D002484) | Dental Implant-Abutment Design (MeSH Unique ID: D059605) | Crown (MeSH Unique ID: D003442) Surfaces | Contour: Crown (MeSH Unique ID: D003442) - Dental Implant (MeSH Unique ID: D015921) AbutmentTurkey
-
National Cheng-Kung University HospitalNot yet recruiting
-
Hacettepe UniversityCompletedCrowns (MeSH Unique ID: D003442), Single Tooth | Dental Porcelain (MeSH Unique ID: D003776)
-
Algemeen Ziekenhuis Maria MiddelaresUnknown
-
Clínica FernándezCompletedRhinoplasty | MeSh E02.218.755Spain
-
Beatrice BaumerUnknownGlycemic Index (MeSH T483740)Switzerland